How AI Is Accelerating Drug Discovery | Smbat Rafayelyan (Bioneex CEO)
About this episode
Smbat Rafayelyan discusses how AI is transforming drug discovery and the role of Bioneex in connecting biotech innovators with investors.
AI in Drug Discovery | #aidrugdiscovery #biotechinnovation #medicalinnovation Amid a rapidly changing biotech landscape, AI is transforming how we discover and develop new medicines. Please visit our website to get more information: https://swangroup.net/ In this episode, I sit down with Smbat Rafayelyan, founder and CEO of Bioneex, a platform that connects early-stage biotech innovators with investors and pharma companies using AI-driven insights. He shares his journey from big pharm...
People in this episode
Host: Steve Swan
Guest: Smbat Rafayelyan
Topics covered
- AI in Drug Discovery
- biotech innovation
- medical innovation
- pharmaceutical IT
- investor connections
Keywords
- AI
- drug discovery
- biotech
- innovation
- pharmaceutical
- investors
- medicine
Mentioned in this episode
Organizations: Bioneex
More episodes of Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders
- Why Diverse Thinking Builds Better AI | Biotech Leadership with Fernando Bardella
- Why Technology Fails Without People | Michael Saitow Explains AI, Innovation & Success
- AI in Pharma Marketing with Nataliya Andreychuk | Pharma Content Strategy
- Why Communication Is the Most Underrated Skill in Biotech Leadership | Michael Piperno
- How AI Is Changing The Way Small Biotechs Grow And Compete - Real Talk With Tyson Kamikawa
- A Year of Biotech Bytes: The Stories, Lessons, and Laughs Behind the Mic
Explore listener stats, chart rankings, contacts and more on the Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders podcast page.